Casi Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$0.92

-0.03 (-2.66%)

As of Feb 8, 2:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,239.8% upside

Low Target $29.11

Average Target $40.13

High Target $50.28

Current Price $0.92

Current
$0.92

Target
$40.13

$29.11 $40.13 avg $50.28

Scenario Analysis

Bear Case

$29.11

3,048.0%

Low target

Base Case

$40.13

+4,239.8%

Avg target

Bull Case

$50.28

+5,337.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$34.87

-97.3% from high

52-Week Low

$20.14

+-95.4% from low

Target vs 52W High

$40.13

+15.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%